China, UAE see positive results in Sinopharm's COVID-19 vaccine trials

China and UAE have obtained some positive results of Phase III COVID-19 vaccine trials, said Chinese foreign ministry spokesperson after Abu Dhabi granted emergency approval to a vaccine candidate. emergency approval for coronavirus vaccine candidate developed by Sipharm, a Chinese company, was granted just six weeks into human trials. 

On September 14, National Emergency Crisis and Disaster Manment Authority said in a statement that vaccine will be available for frontline workers who are at highest risk of contracting virus. anuncement comes amid ar spike in coronavirus cases in Arab state as it reported biggest single-day surge with 1,007 new cases.

“ UAE authorizes emergency use of Covid19 vaccine for members of first line of defense, who are most at risk of catching Covid19, protecting m from any danger taht y may be exposed due to nature of ir work,” re statement.

ncy said that 31,000 volunteers representing 125 nationalities have participated in clinical trials in less than six weeks and results are moving on “right path, with all tests being successful so far.” In a series of tweets, NCEMA said that reported side effects have been mild and expected and severe side effects have been encountered.

Re: RDIF Ties Up With Dr. Reddy’s To Provide 100 Mn Doses Of COVID-19 Vaccine To India

Re: vavax Revises COVID-19 Vaccine Deal With Serum Institute; Aims For 2 Billion Doses

'Encouraging results'

It stressed that initial results in ongoing trials are encouraging in terms of antibody production and emergency approval was given after meeting criteria set for this specific purpose. It ded that health authorities have followed all procedures to control quality, safety and efficacy of vaccine in coordination with vaccine developers.

Earlier in September, China put its COVID-19 vaccine candidates on display for first time as countries race for developing a safe vaccine to prevent coronavirus infection. Chinese government has high hopes from two vaccine candidates produced by Sivac Biotech and Sipharm and both were put on a show at China International Fair for Tre in Services (CIFTIS) in Beijing.

Re: US FDA Investigating AstraZeneca's COVID-19 Vaccine Trial, Says Chief

Re: Trump Says COVID-19 Vaccine May Be Available 'within A Month' At Pennsylvania Convention